| ADR Ontology |
| ADR Term |
Ulnar nerve palsy |
| ADR ID |
BADD_A08445 |
| ADR Hierarchy |
|
| Description |
Disease involving the ULNAR NERVE from its origin in the BRACHIAL PLEXUS to its termination in the hand. Clinical manifestations may include PARESIS or PARALYSIS of wrist flexion, finger flexion, thumb adduction, finger abduction, and finger adduction. Sensation over the medial palm, fifth finger, and ulnar aspect of the ring finger may also be impaired. Common sites of injury include the AXILLA, cubital tunnel at the ELBOW, and Guyon's canal at the wrist. (From Joynt, Clinical Neurology, 1995, Ch51 pp43-5) [MeSH] |
| MedDRA Code |
10059790 |
| MeSH ID |
D020424
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Ulnar nerve palsy | Ulnar Neuropathies | Neuropathies, Ulnar | Neuropathy, Ulnar | Ulnar Neuropathy | Ulnar Nerve Diseases | Nerve Disease, Ulnar | Nerve Diseases, Ulnar | Ulnar Nerve Disease | Ulnar Neuritis | Neuritides, Ulnar | Neuritis, Ulnar | Ulnar Neuritides | Ulnar Nerve Palsy | Nerve Palsies, Ulnar | Nerve Palsy, Ulnar | Palsies, Ulnar Nerve | Palsy, Ulnar Nerve | Ulnar Nerve Palsies |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D01300 | Lisinopril | 0.000042% | | | BADD_D01888 | Quetiapine | 0.000255% | | | BADD_D02010 | Sertraline | 0.000060% | |
| The 1th Page 1
Total 1 Pages
|
|
